Skip to main content
. 2019 Mar 1;2019(3):CD006715. doi: 10.1002/14651858.CD006715.pub3

Summary of findings 2. Epidural analgesia compared with peripheral nerve blocks for cardiac surgery in adult.

Epidural analgesia compared with peripheral nerve blocks for cardiac surgery without cardiopulmonary bypass in adults
Patient or population: adults undergoing cardiac surgery without cardiopulmonary bypass
Settings: trials were conducted in university hospitals in Egypt (n = 1) or India (n = 3)
Intervention: epidural analgesia
Comparison: peripheral nerve blocks (erector spinae plane block (n = 1) or paravertebral blockade (n = 3))
Outcomes Illustrative comparative risks (95% CI)* Risk difference or relative effect
 (95% CI) No. of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Peripheral nerve block Epidural analgesia
Mortallity
 (0 to 30 days Study population RD ‐0.03
(‐0.08 to 0.02)
145
(1 study)
⊕⊝⊝⊝
very lowa
 
43 per 1000 13 per 1000
(2 to 72)
Myocardial infarction
(0 to 30 days)
Study population RD 0.00
(‐0.07 to 0.07)
76
(2 studies)
⊕⊝⊝⊝
very lowa
 
0 per 1000 0 per 1000
(0 to 90)
Pulmonary complications
(0 to 30 days)
We found no data for this outcome (respiratory depression or pneumonia)
Atrial fibrillation or atrial flutter
(0 to 2 weeks)
We found no data for this outcome
Risk of neurological complications
(0 to 30 days)
Cerebrovascular accident
Study population RD 0.00
(‐0.03 to 0.03)
145
(1 study)
⊕⊝⊝⊝
very lowa
 
0 per 1000 0 per 1000
(0 to 49)
Epidural haematoma
Study population RD 0.00
(‐0.03 to 0.03)
271
(4 studies)
⊕⊕⊝⊝
lowb
 
0 per 1000 0 per 1000
(0 to 27)
Duration of tracheal intubation Study population MD ‐0.08 hour
(‐0.54 to 0.38 hour)
271
(4 studies)
⊕⊝⊝⊝
very lowa
 
6.82 ± 2.14 hours (mean ± SD) 6.67 ± 2.31 hours (mean ± SD)
Pain at rest at 6 to 8hours after surgery
(score from 0 to 10)
Study population MD 0.12
(‐0.42 to 0.66)
90
(2 studies)
⊕⊝⊝⊝
very lowa
 
2.20 ± 0.79
(mean ± SD)
1.80 ± 0.22
(mean ± SD)
Haemodynamic support
(in hospital)
Hypotension or need for vasopressor boluses RD 0.05
(‐0.08 to 0.18)
40
(1 study)
⊕⊕⊝⊝
lowb
 
Study population
50 per 1000 0 per 1000
(0 to 161)
Inotropic or vasopressor infusions
We found no data for this outcome
*The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). Confidence intervals were calculated using VassarStats (http://www.vassarstats.net/) with no continuity correction.
 CI: confidence interval; MD: mean difference; RD: risk difference; SD: standard deviation.
GRADE Working Group grades of evidence.
 High quality: further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: we are very uncertain about the estimate.

aDowngraded by one for risk of bias and by two levels for imprecision.

bDowngraded by two levels for imprecision.